Additional Details

  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    University of Wisconsin Clinical Science Center
    Madison WI. 53792
    View Details
  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Temple University Hospital
    Philadelphia PA. 19140
    View Details
  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Stony Brook University
    Stony Brook NY. 91942
    View Details
  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details
  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Clinical Research Specialists
    Kissimmee FL. 34746
    View Details
  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    UC Davis Health System
    Sacramento CA. 95816
    View Details
  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    William Beaumont Hospital - Royal Oak
    Royal Oak MI. 48073
    View Details
  • A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

    Paradigm Clinical Research
    La Mesa CA. 92942
    View Details
  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Potsdam NY. 13676
    View Details
  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Naples FL. 34102
    View Details
  • Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

    MGH Institute of Health Professions
    Charlestown MA. 02129
    View Details
  • Advanced Imaging for Pulmonary Fibrosis

    Massachusetts General Hospital
    Boston MA. 02114
    View Details
  • Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

    MD Anderson Cancer Center
    Houston TX. 77030
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Montréal QC. H2X 0A9
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Edmonton AB. T6G 2C8
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Sherbrooke QC. J1H 5N4
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Vancouver BC. V6Z 2K5
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of California San Francisco
    San Francisco CA. 94143
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of Michigan
    Ann Arbor MI. 48109
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of Kansas
    Kansas City KS. 66103
    View Details